摘要
Chiranjiv CHHABRA 医师
皮肤科医师
Non-cosmetic indications of neurotoxins
Objectives: Along side cosmetic indications we can expand the use of neurotoxins in treating non cosmetic indications like hyperhidrosis,Itch disorders,scar correction,inverse psoriasis,eczema,alopecia,post herpetic neuralgia and many others.It is a wonder drug and has promising outcomes in both cosmetic and non cosmetic therapeutic indications.It is still in the process of discovering newer indications and crossing new frontiers.
Introduction: A German physician Justinus Kerner (1786-1862) first developed the possible therapeutic use of botulinum toxin, which he called “sausage poison”. BoNT-A received US FDA approval for treatment of cervical dystonia.The acceptance of BoNT-A use for the treatment of different chronic pain disorders is growing but is US FDA approved only for chronic migraine.In 2010- the US FDA approved onabotulinumtoxinA to treat spasticity in the flexor muscles of the elbow, wrist, and fingers in adults with stroke, traumatic brain injury& the progression of multiple sclerosis
Materials / method: Mechanism of action of BTX is chemical denervation or preventing the release of acetylcholine into the synaptic cleft.The heavy chain binds to the receptors on the cholinergic nerve endings. This is followed by endocytosis of the molecule and attachment of the light chain to the soluble N-ethylmaleimide-sensitive fusion (SNARE complex) protein receptors after getting cleaved from the heavy chain.The binding of BT to these receptor proteins prevents the attachment of acetylcholine vesicles to the nerve endings and its further release into the synaptic cleft.
Results: There are few non cosmetic indications that can be treated with BTX .Hyperhidrosis,Hidradenitis suppurativa,Post-herpetic neuralgia,Androgenetic Alopecia,Hypertrophic scars/keloids and Trigeminal Neuralgia are few to respond well.
Conclusion: Botulinum toxin is a wonder drug with multiple therapeutic and aesthetic indications and still discovering newer ones and crossing newer frontiers adding quality and value to life.
披露 - Chiranjiv CHHABRA
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2025年 3月 20日 - Recorded during IMCAS World Congress 2025